Reaction
Ureteric Obstruction reporting signals
As of the last recalculation, Ureteric Obstruction appears in 1,352 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is TRIMETHOPRIM (PRR 51.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Trimethoprim | 38 | 51.0 | 51.2 |
| Cephalexin | 29 | 21.1 | 21.1 |
| Indapamide | 23 | 20.1 | 20.1 |
| Trifluridine And Tipiracil | 13 | 18.8 | 18.8 |
| Basiliximab | 14 | 18.5 | 18.5 |
| Ganciclovir | 10 | 15.1 | 15.2 |
| Sodium Bicarbonate | 22 | 14.8 | 14.8 |
| Sodium Bicarbonate Injection, | 22 | 14.8 | 14.8 |
| Ganciclovir Sodium | 10 | 14.6 | 14.7 |
| Nystatin Ointment | 24 | 14.3 | 14.3 |
| Nystatin Cream | 24 | 14.3 | 14.3 |
| Nystatin | 24 | 13.7 | 13.7 |
| Ceftriaxone Sodium | 33 | 13.6 | 13.6 |
| Bicalutamide | 13 | 13.3 | 13.3 |
| Ceftriaxone | 27 | 12.9 | 12.9 |
| Haloperidol | 19 | 12.2 | 12.2 |
| Haloperidol Lactate | 19 | 12.0 | 12.0 |
| Pegaspargase | 9 | 11.4 | 11.4 |
| Tranexamic Acid | 6 | 10.4 | 10.4 |
| Leucovorin Calcium | 12 | 9.7 | 9.7 |
| Filgrastim | 23 | 9.6 | 9.6 |
| Fexofenadine | 10 | 9.4 | 9.4 |
| Polatuzumab Vedotin | 5 | 7.9 | 7.9 |
| Doxorubicin Hydrochloride | 16 | 7.6 | 7.6 |
| Oxaliplatin | 34 | 7.2 | 7.2 |
| Gemcitabine Hydrochloride | 22 | 6.5 | 6.5 |
| Cetuximab | 13 | 6.4 | 6.4 |
| Lapatinib | 6 | 6.0 | 6.0 |
| Leuprolide Acetate | 28 | 5.7 | 5.7 |
| Rucaparib | 3 | 5.2 | 5.2 |
| Enzalutamide | 18 | 4.8 | 4.8 |
| Lutetium Lu 177 Vipivotide Tetraxetan | 3 | 3.5 | 3.5 |